SCHEMBL697284

SCHEMBL697284

Clc1nsc(Cl)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21834512 0.71
SCHEMBL14291320 0.69
SCHEMBL2079340 0.69
SCHEMBL21915884 0.69
SCHEMBL1259877 0.69
SCHEMBL14262471 0.69
SCHEMBL8345883 0.67 ALDH1A1 (0.30)
SCHEMBL352774 0.65
SCHEMBL9508943 0.65
SCHEMBL11459820 0.65 ALDH1A1 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 368 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12565494-B2 Inhibitors of human respiratory syncytial virus and metapneumovirus MERCK SHARP & DOHME LLC 2026-03-03 US disclosed
US-20250339541-A1 ASGPR-BINDING COMPOUNDS FOR THE DEGRADATION OF EXTRACELLULAR PROTEINS AVILAR THERAPEUTICS, INC. (US) 2025-11-06 US disclosed
US-20250333406-A1 SULFONYL CYCLIC DERIVATIVES, AND COMPOSITIONS AND METHODS THEREOF LYSOWAY THERAPEUTICS INC (US) 2025-10-30 US disclosed
EP-4638441-A1 GLYCINE DERIVATIVES WITH P2X4 RECEPTOR-BLOCKING ACTIVITY AS DIAGNOSTICS AND FOR THE TREATMENT OF PAIN, INFLAMMATION, CANCER, AND OTHER P2X4 RECEPTOR-RELATED DISEASES Rheinische Friedrich-Wilhelms-Universität Bonn (DE) 2025-10-29 EP disclosed
US-20250313564-A1 ACIDIC SALT OR CRYSTAL FORM OF NITROGEN-CONTAINING FUSED RING DERIVATIVE INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF SHANGHAI HANSOH BIOMEDICAL CO., LTD. (CN) 2025-10-09 US disclosed
EP-4587435-A1 MODIFIED PROTEINS AND PROTEIN BINDERS AND DEGRADERS Cullgen (Shanghai), Inc. (CN) 2025-07-23 EP disclosed
EP-4585265-A2 HETEROARYL INHIBITORS OF PLASMA KALLIKREIN Takeda Pharmaceutical Company Limited (JP) 2025-07-16 EP disclosed
US-20250223280-A1 POTENT ASGPR-BINDING COMPOUNDS FOR THE DEGRADATION OF IMMUNOGLOBULINS AND OTHER PROTEINS AVILAR THERAPEUTICS, INC. (US) 2025-07-10 US disclosed
US-20250213699-A1 ASGPR-BINDING COMPOUNDS FOR THE DEGRADATION OF EXTRACELLULAR PROTEINS AVILAR THERAPEUTICS, INC. (US) 2025-07-03 US disclosed
US-12312340-B2 Potent ASGPR-binding compounds for the degradation of immunoglobulins and other proteins AVILAR THERAPEUTICS, INC. (US) 2025-05-27 US disclosed
US-20020002171-A1 Materials and methods for killing nematodes and nematode eggs AKKADIX CORPORATION 2002-01-03 US disclosed
WO-2001054506-A1 METHODS FOR KILLING NEMATODES AND NEMATODE EGGS USING BIS-AMINO-1,2,4-THIADIAZOLES AKKADIX CORPORATION (US) 2001-08-02 WO disclosed
EP-0626380-B1 N-(4-Fluorophenyl)-heteroaryloxyacetamide as herbicides BAYER AG (DE) 1999-01-13 EP disclosed
EP-0626380-A1 N-(4-Fluorophenyl)-heteroaryloxyacetamide as herbicides BAYER AG (DE) 1994-11-30 EP disclosed
EP-0348737-B1 HETEROARYLOXY-ACETIC ACID N-ISOPROPYL ANILIDES BAYER AG (DE) 1993-08-04 EP disclosed
US-5090991-A HERBICIDAL N-ISOPROPYLHETEROARYLOXYACETANILIDES BAYER AKATIENGESELLSCHAFT (DE) 1992-02-25 US disclosed
US-4968342-A PRE-AND POSTEMERGENCE BAYER AKTIENGESELLSCHAFT (DE) 1990-11-06 US disclosed
EP-0348737-A1 Heteroaryloxy-acetic acid N-isopropyl anilides BAYER AG (DE) 1990-01-03 EP disclosed
EP-0300344-A1 Halogenated thiadiazolyloxyacetic acid amides, process and intermediates for their preparation and their use as herbicides BAYER AG (DE) 1989-01-25 EP disclosed
US-4081453-A FROM THE 5-ALKYTHIO COMPOUNDS, FUMIGANTS THE O. M. SCOTT & SONS COMPANY (US) 1978-03-28 US disclosed